[go: up one dir, main page]

SMT201300059B - Crema medicinale a base di acido fusidico prodottausando fusidato di sodio e incorporante un biopol inimero e procedimento per la sua produzione - Google Patents

Crema medicinale a base di acido fusidico prodottausando fusidato di sodio e incorporante un biopol inimero e procedimento per la sua produzione

Info

Publication number
SMT201300059B
SMT201300059B SM201300059T SM201300059T SMT201300059B SM T201300059 B SMT201300059 B SM T201300059B SM 201300059 T SM201300059 T SM 201300059T SM 201300059 T SM201300059 T SM 201300059T SM T201300059 B SMT201300059 B SM T201300059B
Authority
SM
San Marino
Prior art keywords
biopolymer
incorporating
production
acid produced
fusidic acid
Prior art date
Application number
SM201300059T
Other languages
English (en)
Italian (it)
Inventor
Vanangamudi Subramaniam Sulur
Madhavan Srinivasan
Neelakandan Narayanan Chulliel
Kuppusamy Senthilkumar
Original Assignee
Vanangamudi Subramaniam Sulur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanangamudi Subramaniam Sulur filed Critical Vanangamudi Subramaniam Sulur
Publication of SMT201300059B publication Critical patent/SMT201300059B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SM201300059T 2009-04-13 2013-06-05 Crema medicinale a base di acido fusidico prodottausando fusidato di sodio e incorporante un biopol inimero e procedimento per la sua produzione SMT201300059B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN960MU2009 2009-04-13
PCT/IB2010/051552 WO2010119385A1 (en) 2009-04-13 2010-04-12 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it

Publications (1)

Publication Number Publication Date
SMT201300059B true SMT201300059B (it) 2013-07-09

Family

ID=42558569

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201300059T SMT201300059B (it) 2009-04-13 2013-06-05 Crema medicinale a base di acido fusidico prodottausando fusidato di sodio e incorporante un biopol inimero e procedimento per la sua produzione

Country Status (19)

Country Link
US (1) US8895542B2 (es)
EP (1) EP2419087B1 (es)
JP (1) JP5205549B2 (es)
KR (1) KR101642537B1 (es)
CN (1) CN102159191B (es)
BR (1) BRPI1006729B1 (es)
CA (1) CA2795611C (es)
CY (1) CY1113885T1 (es)
DK (1) DK2419087T3 (es)
ES (1) ES2404156T3 (es)
HR (1) HRP20130149T1 (es)
IL (1) IL215641A (es)
MX (1) MX2011010784A (es)
PL (1) PL2419087T3 (es)
PT (1) PT2419087E (es)
RU (1) RU2537023C2 (es)
SI (1) SI2419087T1 (es)
SM (1) SMT201300059B (es)
WO (1) WO2010119385A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101457789B1 (ko) 2013-02-13 2014-11-03 동아제약 주식회사 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법
SG11201507141SA (en) * 2013-03-15 2015-10-29 Techulon Inc Antisense molecules for treatment of staphylococcus aureus infection
WO2017091167A1 (en) 2015-11-28 2017-06-01 Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. Topical pharmaceutical composition comprising fusidic acid, isoconazole, dexpanthenol and hydrocortisone
CA3066722A1 (en) 2017-06-12 2018-12-20 Lakewood Amedex, Inc Bisphosphocin gel formulations and uses thereof
CN107224426A (zh) * 2017-07-08 2017-10-03 天津双硕医药科技有限公司 一种含有夫西地酸的外用乳膏组合物
CN111012747B (zh) * 2018-10-10 2022-11-25 四川海思科制药有限公司 一种注射用夫西地酸钠药物组合物及其制备方法
CN114432250B (zh) * 2022-02-22 2022-10-04 深圳市泰力生物医药有限公司 一种非晶态夫西地酸的稳定方法
US20250144008A1 (en) 2023-11-08 2025-05-08 Vishagan Vanangamudi Sulur Compositions and methods for treating skin disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8500310D0 (en) * 1985-01-07 1985-02-13 Leo Pharm Prod Ltd Pharmaceutical preparation
SU1380751A2 (ru) * 1986-03-12 1988-03-15 Всесоюзный научно-исследовательский институт антибиотиков Средство дл лечени гнойно-воспалительных заболеваний кожи и м гких тканей
DK603988D0 (da) * 1988-10-28 1988-10-28 Klaus Bendtzen Farmaceutisk praeparat
TW460296B (en) * 1994-09-01 2001-10-21 Janssen Pharmaceutica Nv Topical ketoconazole emulsion compositions without sodium sulfite
TR200001486T2 (tr) * 1997-11-25 2001-07-23 Yamanouchi Europe B.V. Hiperkeratozlu deri hastalıklarının tedavisi için diol ve alfa-hidroksi asitten oluşan bir karışımın kullanılması
US20070265352A1 (en) * 2002-02-19 2007-11-15 Joachim Roeding Synergistic mixtures of at least one 1,2 alkanediol such as 1,2-hexanediol and 1,2-octanediol with a further compound having antimicrobial properties
ES2204331B1 (es) 2002-10-09 2005-03-01 Ercros Industrial, S.A. Procedimiento para la obtencion de acido fusidico a partir de un caldo de fermentacion.
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
RU2240781C1 (ru) * 2003-06-05 2004-11-27 Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Способ лечения воспалительных процессов вульвы и влагалища
AU2005223351A1 (en) * 2004-03-16 2005-09-29 Glaxo Group Limited Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor
WO2007087806A1 (en) * 2006-02-02 2007-08-09 Leo Pharma A/S A topical composition comprising an antibacterial substance
US9132071B2 (en) * 2006-07-28 2015-09-15 Santen Sas Compositions containing quaternary ammonium compounds
US20080182819A1 (en) * 2007-01-29 2008-07-31 Act Iii Licensing, Llc Chitosan compositions and methods for using chitosan compositions in the treatment of health disorders
WO2010070589A2 (en) 2008-12-19 2010-06-24 Sulur Subramaniam Vanangamudi A novel dermaceutical cream made using sodium fusidate
ES2423231T3 (es) * 2009-02-18 2013-09-18 Sulur Subramaniam Vanangamudi Un proceso para hacer crema de ácido fusídico

Also Published As

Publication number Publication date
CN102159191A (zh) 2011-08-17
RU2537023C2 (ru) 2014-12-27
SI2419087T1 (sl) 2013-06-28
CA2795611A1 (en) 2010-10-21
JP2012523451A (ja) 2012-10-04
IL215641A (en) 2014-09-30
PL2419087T3 (pl) 2013-06-28
PT2419087E (pt) 2013-04-26
US20120040946A1 (en) 2012-02-16
ES2404156T3 (es) 2013-05-24
IL215641A0 (en) 2012-01-31
BRPI1006729B1 (pt) 2021-10-05
MX2011010784A (es) 2012-01-12
CN102159191B (zh) 2014-04-02
KR20120023653A (ko) 2012-03-13
EP2419087A1 (en) 2012-02-22
BRPI1006729A2 (pt) 2020-10-06
WO2010119385A1 (en) 2010-10-21
KR101642537B1 (ko) 2016-07-25
CA2795611C (en) 2016-09-20
EP2419087B1 (en) 2013-01-23
HRP20130149T1 (hr) 2013-03-31
JP5205549B2 (ja) 2013-06-05
US8895542B2 (en) 2014-11-25
DK2419087T3 (da) 2013-05-06
RU2011146230A (ru) 2013-05-20
CY1113885T1 (el) 2016-07-27

Similar Documents

Publication Publication Date Title
SMT201300059B (it) Crema medicinale a base di acido fusidico prodottausando fusidato di sodio e incorporante un biopol inimero e procedimento per la sua produzione
ZA201303568B (en) Method of producing a ppi-containing pharmaceutical preparation
HUE042945T2 (hu) Kvetiapin zsírsav-konjugátumai, eljárás ugyanannak elkészítésére és felhasználására
EP2548965A4 (en) METHOD FOR PRODUCING A SUGAR SOLUTION AND DEVICE THEREFOR
EP2548966A4 (en) METHOD FOR PRODUCING A SUGAR SOLUTION AND DEVICE THEREFOR
EP2701508A4 (en) MANUFACTURE AND DELIVERY OF A STABLE COLLAGEN
DK3284459T3 (en) Pharmaceutical compositions comprising a local anaesthetic such as Bupivacaine for local administration to the mouth or throat
FR2948364B1 (fr) Procede de preparation d'un fluorure d'halogenoacetyle et de ses derives
SMT201500204B (it) Procedimento per preparare un acido bivenil-2-il carbammico
BRPI1015297A2 (pt) "método para a preparação de produtos de clivagem de carboidratos a partir de um material lignocelulósico".
EP2879510A4 (en) PREPARATION OF SOLUBLE PROTEIN PRODUCTS FROM HEMP (H701)
BR112012024034A2 (pt) produto de confeitaria e métodos de sua produção
BR112012013424A2 (pt) produção de esteróis não-leveduras por leveduras
ITUD20110133A1 (it) "sensore di integrazione ad azione ritardata cmos per applicazione in produzione di immagini a raggi x"
EP2448423A4 (en) PREPARATION OF ACID SOLUBLE SOY PROTEIN ISOLATES (S700)
FR2954313B1 (fr) Procede de preparation de dithiocarbamates notamment a partir de polyols du type glycerol.
BRPI0920124A2 (pt) produto farmacêutico para aumentar a dose de vacina contra alergia
FI20080348A0 (fi) Uudenlainen farmaseuttinen formulaatio
EP2788516A4 (en) STARTING A MELTING PROCESS
PL2403480T3 (pl) Sposób wytwarzania kremu z kwasem fusydowym
WO2010134048A3 (en) Topical retinoid solutions
EP2728904A4 (en) VIBRATING ELEMENT AND METHOD FOR PRODUCING A VIBRANT ELEMENT
EP2788514A4 (en) STARTING A MELTING PROCESS
IT1394296B1 (it) Metodo di sintesi dell'acido glicocolico.
HU1000444D0 (en) Process for the preparation of a pharmaceutical active ingredient